Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 530-534

  Alarcón, Graciela S ^a,b   Bartolucci, Alfred A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b The University of Alabama at Birmingham   (United States)

Author keywords

Methotrexate; Minocycline; Radiographs; Rheumatoid Arthritis

Indexed keywords

AZATHIOPRINE; GOLD SALT; METHOTREXATE; MINOCYCLINE;

ARTHROPATHY; BONE EROSION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; RHEUMATOID ARTHRITIS;

ANTI-BACTERIAL AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; MINOCYCLINE; TREATMENT OUTCOME;

EID: 0033969198     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Tugwell P, Bennett K, Gent M. Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety. Ann Intern Med 1987;107:358-66.
2. Kremer JM. Methotrexate 1989 - the evolving story. J Rheumatol 1989;16:261-3.
3. Alarcón GS, Tracy IC, Blackburn WDJ. Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989;32:671-6.
4. Harris ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
5. Alarcón GS, López-Méndez A, Walter J, et al. Radiographic evidence of disease progression in methotrexate treated and non-methotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: A meta-analysis. J Rheumatol 1992;19:1868-73.
6. Bartolucci AA, Katholi CR, Singh KP, Alarcón GS. Issues in meta-analysis: An overview. Arthritis Care Res 1994;7:156-9.
7. Felson DT. Meta-analysis and rheumatology. Cliniguide Rheumatol 1992;2:1-7.
8. Sharp, JT, Young DY, Bluhm GB, et al. How many joints in the hands and wrists should be included in the score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
9. Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando: Academic Press; 1985.
10. Duffie FC. Meta-analysis of the effect of methotrexate on radiologie progression in rheumatoid arthritis [letter]; Alarcón GS [reply]. J Rheumatol 1993;20:1623.
11. Rich E, Moreland LW, Alarcón GS. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug. J Rheumatol 1999;26:259-61.
12. Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans AC. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 1994;37:629-36.
13. O'Dell J, Klassen LW, Haire C, et al. Treatment of early rheumatoid arthritis with minocycline or placebo. Arthritis Rheum 1997;40:842-8.
14. Bluhm GB, Sharp JT, Tilley B, et al. Radiographic results from the Minocycline in Rheumatoid Arthritis trial (MIRA). J Rheumatol 1997;24:1295-302.
15. Tilley BC, Alarcón GS, Heyse SP, et al. Minocycline in rheumatoid arthritis: a 48 week, double-blind, placebo-controlled trial. Ann Intern Med 1995;122:81-9.
16. Reveille JD, Alarcón GS, Fowler SE, et al. HLA-DRB1 genes and disease severity in rheumatoid arthritis. Arthritis Rheum 1996;39:1802-7.
17. Felson DT. Choosing a core set of disease activity measures for rheumatoid arthritis clinical trials. J Rheumatol 1993;20:531-4.
18. Sharp JT. Scoring radiographic abnormalities in rheumatoid arthritis. Radiol Clin N Am 1996;34:233-41.
19. Molenaar THE, Boers M, van der Heijde DMFM, et al. Imaging in rheumatoid arthritis: results of group discussion. J Rheumatol 1999;26:749-51.